Liver resection for hepatocellular carcinoma in patients with hematological malignancies

World Journal of Surgical Oncology
Hui-Chen LinFang-Ku P'eng

Abstract

Improvements in antimetabolite drugs have prolonged the survival of patient with hematological malignancies. However, these drugs may have hepatotoxic side effects and may induce acute liver failure, chronic liver fibrosis, cirrhosis, or even hepatocellular carcinoma (HCC). Although liver resection remains a curative option for HCC, its role in HCC with hematological malignancies has never been fully explored. A retrospective review of 1725 patients who underwent curative liver resection for newly diagnosed HCC between 1994 and 2016 was conducted. Among these patients, 16 had a history of hematological malignancies (HM group). Their hematological malignancies were well-controlled at the time of liver resection. The clinicopathological characteristics of the HM group, along with their short- and long-term outcomes after liver resection, were compared with those of the other 1709 patients without hematological malignancy (non-HM group). All HM group patients were seropositive for hepatitis marker surface for hepatitis B and C. No significant differences were observed in any background characteristics between the two groups. The postoperative complication rate and 90-day mortality in the HM and non-HM groups were 25 and 20.4%, P =...Continue Reading

References

Aug 1, 1973·The British Journal of Surgery·R N PughR Williams
Sep 1, 1984·Experimental Cell Research·N B Hecht, H Liem
Jun 1, 1995·Journal of Hepatology·K IshakR N MacSween
Feb 13, 2001·The British Journal of Surgery·C C WuF K P'Eng
Dec 18, 2001·Journal of Surgical Oncology·S B ChengF K P'eng
Jun 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jinfeng HuangShuhan Sun
Nov 21, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Ann Lii ChengJoong-Won Park
Mar 19, 2014·Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti·L KoubkováR Vyzula
Mar 19, 2014·Annals of Coloproctology·Jin Woo LeeNam Keun Kim
Sep 4, 2015·The British Journal of Surgery·J SavikkoH Isoniemi
Feb 6, 2017·Japanese Journal of Clinical Oncology·Cheng-Chung Wu

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.